Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
María Trujillo‐Rodríguez(Instituto de Biomedicina de Sevilla), Luís F. López‐Cortés(Instituto de Salud Carlos III), Joana Vitallé(Instituto de Biomedicina de Sevilla), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Jorge Julio Cabrera(University Hospital Complex Of Vigo), Alberto Pérez‐Gómez(Instituto de Biomedicina de Sevilla), Carmen Gasca‐Capote(Instituto de Biomedicina de Sevilla), Luis Eduardo López-Cortés(Madrid Institute for Advanced Studies), Juan Manuel Praena‐Fernández(Universidad de Granada), Eva Poveda(Madrid Health Service), Zaira R. Palacios‐Baena(Hospital Universitario Virgen Macarena), Esperanza Muñoz‐Muela(Instituto de Biomedicina de Sevilla), Alicia Gutiérrez‐Valencia(Consejo Superior de Investigaciones Científicas), Ana Serna‐Gallego(Instituto de Biomedicina de Sevilla), Joaquim Peraire(Instituto de Salud Carlos III), Ezequiel Ruíz-Mateos(Apple (Israel))
Cited by 5
Related Papers
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
|AIDS|2004|115
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
|The Lancet Infectious Diseases|2021|104